Patents by Inventor Michael Paradowski

Michael Paradowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250197368
    Abstract: The present invention provides compounds of formula (I), as well as pharmaceutically acceptable salts thereof, wherein X1, L1, R1, R2, R3, R4, Ring A, n and p are as described herein. The compounds of the present invention have affinity for ?2- and/or ?3-subunit-containing GABAA receptors. The present invention further provides the manufacture of the compounds of formula (I), pharmaceutical compositions comprising the compounds and their use as medicaments for the treatment of diseases and disorders associated with ?2- and/or ?3-GABAA receptors, including, for example anxiety disorders.
    Type: Application
    Filed: October 13, 2021
    Publication date: June 19, 2025
    Inventors: Samuele Maramai, Alessandro Mazzacani, Michael Paradowski, Simon Ward
  • Patent number: 10106539
    Abstract: Benzimidazoles of formula (I): wherein: one of X and Y is an N atom or a substituted C atom, and the other is CH; L is a single bond, C1-3 alkylene, C2-3 alkenylene or C2-3 alkynylene; R1 is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, 3- to 10-membered cycloalkyl, 5- to 10-membered heterocyclyl or 5- to 12-membered heteroaryl, each of which is unsubstituted or substituted; Z is halo, C1-6 haloalkyl, nitro, —CN, —N(R2)2, —OR2, —SR2, —S(=0)R2, or —S(=0)2R2; each R2 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, wherein said alkyl, alkenyl and alkynyl groups are unsubstituted or substituted; and m is 0 or 1; and the pharmaceutically acceptable salt thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 23, 2018
    Assignee: REVIRAL LIMITED
    Inventors: Stuart Cockerill, Neil Mathews, Simon Ward, Graham Lunn, Michael Paradowski, Jose Miguel Gascon Simorte
  • Publication number: 20170305908
    Abstract: Benzimidazoles of formula (I): wherein: one of X and Y is an N atom or a substituted C atom, and the other is CH; L is a single bond, C1-3 alkylene, C2-3 alkenylene or C2-3 alkynylene; R1 is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, 3- to 10-membered cycloalkyl, 5- to 10-membered heterocyclyl or 5- to 12- membered heteroaryl, each of which is unsubstituted or substituted; Z is halo, C1-6 haloalkyl, nitro, —CN, —N(R2)2, —OR2, —SR2, —S(?0)R2, or —S(?0)2R2; each R2 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, wherein said alkyl, alkenyl and alkynyl groups are unsubstituted or substituted; and m is 0 or 1; and the pharmaceutically acceptable salt thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Applicant: REVIRAL LIMITED
    Inventors: Stuart Cockerill, Neil Mathews, Simon Ward, Graham Lunn, Michael Paradowski, Jose Miguel Gascon Simorte